Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors

Published:2018-08-06 Issue:10 Volume:7 Page:1-9
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Lin Zhiyuan¹,Liu Li¹,Xia Yu¹,Chen Xiang¹,Xiong Ying¹,Qu Yang¹,Wang Jiajun¹,Bai Qi¹,Guo Jianming¹,Xu Jiejie²^ORCID

Affiliation:

1. Department of Urology, Zhongshan Hospital, Fudan University, Shanghai China

2. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai China

Funder

National Natural Science Foundation of China

Zhongshan Hospital Talented Youth Program

Zhongshan Hospital Science Foundation

Shanghai Health and Family Planning Commission

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1477461

Reference46 articles.

1. Global cancer statistics, 2012

2. Cancer statistics, 2017

3. Renal-Cell Carcinoma

4. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

5. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib;Journal of Cancer Research and Clinical Oncology;2024-05-19

2. Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study;BMC Cancer;2024-04-09

3. Prognostic and immunological role of adaptor related protein complex 3 subunit mu2 in colon cancer;Scientific Reports;2024-01-04

4. The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer;Cell Transplantation;2024-01

5. Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature;Scientific Reports;2023-10-16